Search Results

Angel Torres was running out of options. After multiple rounds of chemotherapy and a fruitless search for a bone marrow donor, the 3-year-old’s odds against acute lymphoblastic leukemia were grim. That changed in June, when Phoenix Children’s providers recommended CAR-T cellular therapy, a breakthrough new treatment that uses a patient’s own T-cells to attack and destroy cancer cells. Only available at a handful of children’s cancer centers nationwide, CAR-T worked for Angel, destroying the leukemia cells and giving him a second chance at life.

Phoenix Children’s ranked No. 17 on the 2022 “Healthiest 100 Workplaces in America,” an awards program from Healthiest Employers® honoring organizations investing in the health and well-being of their employees. The health system jumped 54 places in the rankings compared to last year, when Phoenix Children’s was named No. 71 in the country.

Nationally ranked pediatric leader, Phoenix Children’s Hospital, is the first-ever health system in the U.S. to receive and deploy the newly FDA-cleared Medtronic Stealth Autoguide™ platform. Medtronic, a global leader in medical technology, chose Barrow Neurological Institute (BNI) at Phoenix Children’s as its first partner using this robotic technology. The highly advanced surgical tool is intended for use with the Medtronic StealthStation™ system, and Phoenix Children’s Hospital will use it in surgery for pediatric patients suffering from a range of neurological conditions.